Abstract:Kai Wu, 1, * Qiong Feng, 2, * Liang Li, 1 Yanfei Xiong, 3 Shihong Liu, 4 Jie Liu, 1 Qing Wu 1 1 Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang 300006, People's Republic of China; 2 Nursing School, Nanchang University, Nanchang 300006, People's Republic of China; 3 Department of Orthopedics, Jingan Hospital, Yichun 330600, People's Republic of China; 4 Jingan Hospital of Traditional Chinese Medicine, Yichun 330600, People's Republic of China *These authors contributed equally to this work Correspondence: Qing Wu Email wuqing18186@126.com Introduction: The long-noncoding RNA PCAT6 plays an important regulatory role in the development of several cancers. However, the expression pattern and underlying mechanisms of PCAT6 in osteosarcoma (OS) are yet unknown. Methods: We used real-time PCR to measure PCAT6 expression in 106 tumor pairs and corresponding non-tumor tissues from OS patients. Statistical analyses were applied to evaluate the prognostic value and associations of PCAT6 expression with clinical parameters. Furthermore, the PCAT6 was silenced with siRNA in OS cells. Moreover, phenotype of PCAT6 silenced OS cells was measured using colony formation, CCK-8, cell migration and invasion assay. Finally, the molecular mechanism of PCAT6/miR-143-3p/ZEB1 axis in OS progression was explored. Results: The expression level of PCAT6 in OS tissues was significantly elevated as compared with that in the adjacent normal bone tissues and that high PCAT6 expression closely correlated with the malignant phenotype and poor survival among patients with OS. Multivariate analyses revealed PCAT6 overexpression as an independent prognostic factor for the poor outcome of patients with OS. Functional assay results demonstrated that the knockdown of PCAT6 expression notably suppressed the proliferation, migration, and invasion of OS cells. An elevated PCAT6 level aggravated the malignant phenotype of OS cells via ZEB1 expression upregulation. Mechanistic studies revealed that PCAT6 could sponge endogenous miR-143-3p and inhibit its activity, resulting in an increase in ZEB1 level. Finally, we demonstrated that the tumour-promoting role of PCAT6 in OS was dependent on the regulation of the miR-143-3p/ZEB1 axis. Conclusion: These findings highlight the potential role of PCAT6, which could serve as a valuable prognostic indicator for patients with OS. Keywords: osteosarcoma, PCAT6, ZEB1, miR-143-3p

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

COL12A1 Promotes Osteosarcoma Progression via the FAK/PI3K/AKT/mTOR Pathway

Chondroitin Polymerizing Factor (CHPF) Promotes Cell Proliferation and Tumor Growth in Human Osteosarcoma by Inhibiting SKP2's Ubiquitination While Activating the AKT Pathway

CircRNA-CIRH1A Promotes the Development of Osteosarcoma by Regulating PI3K/AKT and JAK2/STAT3 Signaling Pathways

CDKL3 Promotes Osteosarcoma Progression by Activating Akt/PKB

Promotion of Proliferation and Inhibition of Apoptosis by Diacylglycerol Kinase Zeta, a Potential Oncogene of Osteosarcoma

High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation Through the Β-Catenin/wnt Signaling Pathway and is Associated with Poor Prognosis

The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling.

SLC3A2 is Upregulated in Human Osteosarcoma and Promotes Tumor Growth Through the PI3K/Akt Signaling Pathway.

CEP55 Promotes the Proliferation and Invasion of Tumour Cells Via the AKT Signalling Pathway in Osteosarcoma

Hypoxia-inducible Factor-1 Promotes Cancer Progression Through Activating AKT/Cyclin D1 Signaling Pathway in Osteosarcoma

ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway

ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway

Long-Noncoding RNA PCAT6 Aggravates Osteosarcoma Tumourigenesis via the MiR-143-3p/ZEB1 Axis

SOX12 Promotes Stem Cell-Like Phenotypes and Osteosarcoma Tumor Growth by Upregulating JAGGED1

SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling.

Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma

Macrophage-derived CCL18 Promotes Osteosarcoma Proliferation and Migration by Upregulating the Expression of UCA1